BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 19691556)

  • 1. Adjuvants for malaria vaccines.
    Coler RN; Carter D; Friede M; Reed SG
    Parasite Immunol; 2009 Sep; 31(9):520-8. PubMed ID: 19691556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New horizons in adjuvants for vaccine development.
    Reed SG; Bertholet S; Coler RN; Friede M
    Trends Immunol; 2009 Jan; 30(1):23-32. PubMed ID: 19059004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RTS,S vaccine candidate for malaria.
    Regules JA; Cummings JF; Ockenhouse CF
    Expert Rev Vaccines; 2011 May; 10(5):589-99. PubMed ID: 21604980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New concepts in vaccine development in malaria.
    Kanoi BN; Egwang TG
    Curr Opin Infect Dis; 2007 Jun; 20(3):311-6. PubMed ID: 17471043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the clinical development of candidate malaria vaccines.
    Ballou WR; Arevalo-Herrera M; Carucci D; Richie TL; Corradin G; Diggs C; Druilhe P; Giersing BK; Saul A; Heppner DG; Kester KE; Lanar DE; Lyon J; Hill AV; Pan W; Cohen JD
    Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):239-47. PubMed ID: 15331843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preerythrocytic malaria vaccine development.
    Mikolajczak SA; Aly AS; Kappe SH
    Curr Opin Infect Dis; 2007 Oct; 20(5):461-6. PubMed ID: 17762778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Vaccine Initiative: lessons from developing malaria vaccines.
    Geels MJ; Imoukhuede EB; Imbault N; van Schooten H; McWade T; Troye-Blomberg M; Dobbelaer R; Craig AG; Leroy O
    Expert Rev Vaccines; 2011 Dec; 10(12):1697-708. PubMed ID: 22085173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines against malaria - an update.
    Matuschewski K; Mueller AK
    FEBS J; 2007 Sep; 274(18):4680-7. PubMed ID: 17824954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of RTS,S/AS02: a purified subunit-based malaria vaccine candidate formulated with a novel adjuvant.
    Garçon N; Heppner DG; Cohen J
    Expert Rev Vaccines; 2003 Apr; 2(2):231-8. PubMed ID: 12899574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for determining vaccine efficacy and effectiveness and the main barriers to developing a fully deployable malaria vaccine.
    Guinovart C; Alonso PL
    Am J Trop Med Hyg; 2007 Dec; 77(6 Suppl):276-81. PubMed ID: 18165503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular adjuvants for malaria DNA vaccines based on the modulation of host-cell apoptosis.
    Bergmann-Leitner ES; Leitner WW; Duncan EH; Savranskaya T; Angov E
    Vaccine; 2009 Sep; 27(41):5700-8. PubMed ID: 19576940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of combination adjuvants for malaria vaccines: a promising approach for vaccine development.
    Pirahmadi S; Zakeri S; Djadid ND; Mehrizi AA
    Int J Parasitol; 2021 Aug; 51(9):699-717. PubMed ID: 33798560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of the RTS,S malaria vaccine candidate: challenges and lessons.
    Ballou WR
    Parasite Immunol; 2009 Sep; 31(9):492-500. PubMed ID: 19691554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine adjuvants: scientific challenges and strategic initiatives.
    Harandi AM; Davies G; Olesen OF
    Expert Rev Vaccines; 2009 Mar; 8(3):293-8. PubMed ID: 19249971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving vaccine performance with adjuvants.
    Vogel FR
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S266-70. PubMed ID: 10875797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asexual blood-stage malaria vaccine development: facing the challenges.
    Genton B; Reed ZH
    Curr Opin Infect Dis; 2007 Oct; 20(5):467-75. PubMed ID: 17762779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria vaccines and the new malaria agenda.
    Greenwood BM; Targett GA
    Clin Microbiol Infect; 2011 Nov; 17(11):1600-7. PubMed ID: 21883665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical malaria vaccine development.
    Sauerwein RW
    Immunol Lett; 2009 Feb; 122(2):115-7. PubMed ID: 19100773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of human-use adjuvants.
    Kenney RT; Edelman R
    Expert Rev Vaccines; 2003 Apr; 2(2):167-88. PubMed ID: 12899569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral vectors in malaria vaccine development.
    Limbach KJ; Richie TL
    Parasite Immunol; 2009 Sep; 31(9):501-19. PubMed ID: 19691555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.